Reena Shakya

3.6k total citations · 1 hit paper
41 papers, 2.6k citations indexed

About

Reena Shakya is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Reena Shakya has authored 41 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Genetics. Recurrent topics in Reena Shakya's work include Pancreatic and Hepatic Oncology Research (8 papers), Renal and related cancers (6 papers) and Cancer Genomics and Diagnostics (5 papers). Reena Shakya is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Renal and related cancers (6 papers) and Cancer Genomics and Diagnostics (5 papers). Reena Shakya collaborates with scholars based in United States, United Kingdom and Japan. Reena Shakya's co-authors include Frank Costantini, Tomoko Watanabe, Thomas Ludwig, Jonathan D. Licht, Richard Baer, Matthias Szabolcs, Wei Hsu, Patricia D. Wilson, M. Albert Basson and Ivor Mason and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Reena Shakya

40 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

2016 401 citations Thomas A. Mace, Reena Shakya et al. Gut profile →

Peers

Countries citing papers authored by Reena Shakya

Since Specialization

Citations

This map shows the geographic impact of Reena Shakya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reena Shakya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reena Shakya more than expected).

Fields of papers citing papers by Reena Shakya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reena Shakya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reena Shakya. The network helps show where Reena Shakya may publish in the future.

Co-authorship network of co-authors of Reena Shakya

This figure shows the co-authorship network connecting the top 25 collaborators of Reena Shakya. A scholar is included among the top collaborators of Reena Shakya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reena Shakya. Reena Shakya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of a photodynamic therapy agent using a canine prostate cancer model 2023 ·The Prostate ·Dong Luo, Xinning Wang, Gopalakrishnan Ramamurthy, (unknown), Lifang Zhang, (unknown), (unknown), Clemens Burda, Reena Shakya, Eric T. Hostnik, (unknown), Lee Ponsky, Vladimir Ponomarev, Thomas J. Rosol, Michael F. Tweedle, James P. Basilion	4
2	EMT alterations in the solute carrier landscape uncover SLC22A10/A15 imposed vulnerabilities in pancreatic cancer 2022 ·iScience ·Debasis Nayak, (unknown), Avinash K. Persaud, (unknown), Reena Shakya, Junan Li, Moray J. Campbell, Rajgopal Govindarajan	5
3	KMT2D loss drives aggressive tumor phenotypes in cutaneous squamous cell carcinoma. 2022 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Abigail J. Beer, Johnny R. Ramroop, (unknown), Dawn C. Allain, Reena Shakya, Sue E. Knoblaugh, (unknown), Amanda E. Toland	12
4	CD200 promotes immunosuppression in the pancreatic tumor microenvironment 2020 ·Journal for ImmunoTherapy of Cancer ·Fouad Choueiry, (unknown), Reena Shakya, (unknown), (unknown), Brooke Benner, Alice Hinton, (unknown), Bradley W. Blaser, Anne M. Noonan, Terence M. Williams, Mary Dillhoff, Darwin L. Conwell, Phil A. Hart, Zobeida Cruz‐Monserrate, Xue‐Feng Bai, William E. Carson, Thomas A. Mace	61
5	Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging 2020 ·Journal of Visualized Experiments ·(unknown), (unknown), (unknown), Anna Bratasz, Reena Shakya, Kimerly Powell, Gina M. Sizemore	9
6	Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains 2019 ·PLoS ONE ·Dongju Park, Reena Shakya, Christopher S. Koivisto, Jason R. Pitarresi, Matthias Szabolcs, Raleigh D. Kladney, (unknown), Thomas A. Mace, Thomas Ludwig	7
7	Modeling Human Cancer-induced Cachexia 2019 ·Cell Reports ·Erin E. Talbert, Maria C. Cuitiño, Katherine J. Ladner, (unknown), Melissa Siebert, Reena Shakya, Gustavo Leone, Michael C. Ostrowski, (unknown), Noah Weisleder, Peter J. Reiser, Amy Webb, Cynthia Timmers, Daniel Eiferman, David C. Evans, Mary Dillhoff, Carl Schmidt, Denis C. Guttridge	93
8	Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes 2019 ·npj Systems Biology and Applications ·Kelly Regan, Jielin Xu, (unknown), Megan Duggan, Reena Shakya, (unknown), William E. Carson, Philip Payne, Fuhai Li	34
9	The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors 2017 ·Molecular Cancer Therapeutics ·Matthew R. Farren, (unknown), Reena Shakya, (unknown), Gregory Young, Kari Kendra, Yosef Landesman, Sivan Elloul, Marsha Crochiere, Boris Klebanov, Trinayan Kashyap, Christin E. Burd, Gregory B. Lesinski	23
10	Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth 2016 ·Molecular Cancer Research ·Xiangnan Guan, Kyle M. LaPak, (unknown), Christina Y. Yu, Reena Shakya, Jianying Zhang, Christin E. Burd	81
11	IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer breakdown → 2016 ·Gut ·Thomas A. Mace, Reena Shakya, Jason R. Pitarresi, Benjamin Swanson, Christopher McQuinn, Shannon Loftus, Emily Nordquist, Zobeida Cruz‐Monserrate, Lianbo Yu, Gregory Young, Xiaoling Zhong, Teresa A. Zimmers, Michael C. Ostrowski, Thomas Ludwig, Mark Bloomston, Tanios Bekaii‐Saab, Gregory B. Lesinski	401
12	The Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor Progression 2014 ·Cancer Research ·Adam M. Sonabend, Mukesh Bansal, Paolo Guarnieri, Lei Liang, Benjamin Amendolara, Craig Soderquist, (unknown), Jonathan Yun, Benjamin C. Kennedy, Julia Sisti, Samuel S. Bruce, (unknown), Reena Shakya, Thomas Ludwig, Steven S. Rosenfeld, Peter A. Sims, Jeffrey N. Bruce, Andrea Califano, Peter Canoll	41
13	Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma 2012 ·Cancer Research ·Reena Shakya, Tamas A. Gonda, Michael Quante, Martha Salas, Samuel Kim, (unknown), Steffen Hirsch, Justine Davies, (unknown), Kenneth P. Olive, Timothy C. Wang, Matthias Szabolcs, Benjamin Tycko, Thomas Ludwig	62
14	Ret-Dependent Cell Rearrangements in the Wolffian Duct Epithelium Initiate Ureteric Bud Morphogenesis 2009 ·Developmental Cell ·Xuan Chi, Odyssé Michos, Reena Shakya, Paul Riccio, Hideki Enomoto, Jonathan D. Licht, Naoya Asai, Masahide Takahashi, Nobutaka Ohgami, Masashi Kato, Cathy Mendelsohn, Frank Costantini	174
15	E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks 2008 ·Proceedings of the National Academy of Sciences ·(unknown), Reena Shakya, (unknown), Maria Lokshin, Jiin‐Tsuey Cheng, Maria Jasin, Richard Baer, Thomas Ludwig	104
16	The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression 2008 ·Proceedings of the National Academy of Sciences ·Reena Shakya, Matthias Szabolcs, (unknown), (unknown), Katia Basso, Subhadra V. Nandula, Vundavalli V. Murty, Richard Baer, Thomas Ludwig	104
17	GDNF/Ret signaling and the development of the kidney 2006 ·BioEssays ·Frank Costantini, Reena Shakya	243
18	The role of GDNF in patterning the excretory system 2005 ·Developmental Biology ·Reena Shakya, Eek‐hoon Jho, (unknown), Zaiqi Wu, Nikolai Kholodilov, Robert E. Burke, Vivette D. D’Agati, Frank Costantini	54
19	Sprouty1 Is a Critical Regulator of GDNF/RET-Mediated Kidney Induction 2005 ·Developmental Cell ·M. Albert Basson, (unknown), Judy Watson-Johnson, Ruth Simon, Thomas J. Carroll, Reena Shakya, Isabelle Groß, Gail R. Martin, Thomas Lufkin, Andrew P. McMahon, Patricia D. Wilson, Frank Costantini, Ivor Mason, Jonathan D. Licht	284
20	The Role of GDNF/Ret Signaling in Ureteric Bud Cell Fate and Branching Morphogenesis 2005 ·Developmental Cell ·Reena Shakya, Tomoko Watanabe, Frank Costantini	205

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact